Oncothyreon Has Big Plans For Alpine Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
One Seattle biotech took over another Seattle biotech in hopes of making a stronger oncology player that has the capabilities to develop its own drugs. It also hopes the acquisition will give it more business development opportunities.